Document Detail


New technologies for cervical cancer screening.
MedLine Citation:
PMID:  22119058     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
New technologies for cervical cancer screening seek to provide an accurate, efficient and cost-effective way of identifying women at risk for cervical cancer. Current screening uses human papilloma virus DNA testing combined with cytology, and requires multiple visits at a great cost to the patient and society. New methods for screening include HPV diagnostics (detection of either the presence of human papilloma virus or integration of the virus into the host cell), proliferation, and detection of epigenetic changes, either in the host or virus. These methods show promise in changing the way that current cervical cancer screening is undertaken in low-and high-resource settings.
Authors:
Alaina J Brown; Cornelia L Trimble
Related Documents :
22032838 - There is no decision to make: experiences and attitudes toward treatment-focused geneti...
21952578 - Cultural perspectives in cancer care: impact of islamic traditions and practices in mid...
21895958 - Intra-operative frozen section analysis for suspected early-stage ovarian cancer: 11 ye...
22128288 - Future directions in the evaluation of c-met-driven malignancies.
8652238 - Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy.
15186048 - Should coal tar products carry cancer warnings?
Publication Detail:
Type:  Journal Article; Review     Date:  2011-11-25
Journal Detail:
Title:  Best practice & research. Clinical obstetrics & gynaecology     Volume:  26     ISSN:  1532-1932     ISO Abbreviation:  Best Pract Res Clin Obstet Gynaecol     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-05     Completed Date:  2012-06-21     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  101121582     Medline TA:  Best Pract Res Clin Obstet Gynaecol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  233-42     Citation Subset:  IM    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Affiliation:
Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cervical Intraepithelial Neoplasia / diagnosis*,  economics,  virology
Cost-Benefit Analysis
Early Detection of Cancer / methods*
Female
Humans
Papillomaviridae / genetics,  isolation & purification*
Papillomavirus Infections / diagnosis*,  economics
Tumor Markers, Biological / analysis
Uterine Cervical Neoplasms / diagnosis*,  economics,  virology
Vaginal Smears / economics
Grant Support
ID/Acronym/Agency:
P30 CA006973/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of haematological malignancy in pregnancy.
Next Document:  Love is more than just a kiss: A neurobiological perspective of love and affection.